Canopy Growth Corp (TSE:WEED – Get Free Report) shares hit a new 52-week low on Tuesday. The stock traded as low as C$1.00 and last traded at C$1.02, with a volume of 171,832 shares trading hands. The stock had previously closed at C$1.02.
Canopy Growth Stock Performance
The company’s 50 day simple moving average is C$1.31 and its two-hundred day simple moving average is C$1.38. The company has a quick ratio of 2.32, a current ratio of 3.04 and a debt-to-equity ratio of 40.27. The company has a market capitalization of C$431.50 million, a price-to-earnings ratio of -1.52, a P/E/G ratio of -0.01 and a beta of 2.41.
Canopy Growth (TSE:WEED – Get Free Report) last issued its quarterly earnings results on Friday, August 7th. The company reported C($0.03) earnings per share (EPS) for the quarter. Canopy Growth had a negative return on equity of 29.85% and a negative net margin of 73.95%. The business had revenue of C$81.17 million for the quarter. As a group, research analysts anticipate that Canopy Growth Corp will post -0.69 earnings per share for the current fiscal year.
Insider Buying and Selling at Canopy Growth
In related news, Director David Angelo Lazzarato sold 22,380 shares of the business’s stock in a transaction on Monday, September 28th. The stock was sold at an average price of C$1.29, for a total transaction of C$28,870.20. Following the transaction, the director directly owned 108,237 shares in the company, valued at C$139,625.73. The trade was a 17.13% decrease in their position. Over the last ninety days, insiders sold 43,492 shares of company stock valued at $56,105. 0.21% of the stock is owned by company insiders.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Further Reading
- Five stocks we like better than Canopy Growth
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
- IonQ’s Bold Expansion Could Leave Shareholders Paying the Price
- Powering Up: Applied Digital Execs Buy $6.7M in Stock
- Chip Stocks Are Sliding—Why Is Smart Money Buying?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
